(Q42870699)

9 November 2017

Cross-reactive Antibodies against avian influenza virus A (H5N1). (English)

1 reference

9 November 2017

1 reference

12

Carl J Mason

1 reference

9 November 2017

2

Anan Jongkaewwattana

1 reference

9 November 2017

11

Stitaya Sirisinha

1 reference

9 November 2017

Pongsak Utaisincharoen

10

object named as

Pongsak Utaisincharoen

1 reference

9 November 2017

Sathit Pichyangkul

1

1 reference

9 November 2017

Arunee Thitithanyanont

3

1 reference

9 November 2017

Peeraya Ekchariyawat

4

1 reference

9 November 2017

Suwimon Wiboon-ut

5

1 reference

9 November 2017

Amporn Limsalakpetch

6

1 reference

9 November 2017

Kosol Yongvanitchit

7

1 reference

9 November 2017

Utaiwan Kum-Arb

8

1 reference

9 November 2017

Rangsini Mahanonda

9

1 reference

9 November 2017

Mark M Fukuda

13

1 reference

9 November 2017

1 September 2009

1 reference

Emerging Infectious Diseases

9 November 2017

1 reference

9 November 2017

15

1 reference

9 November 2017

9

1 reference

9 November 2017

1537-1539

1 reference

High susceptibility of human dendritic cells to avian influenza H5N1 virus infection and protection by IFN-alpha and TLR ligands.

9 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819863

Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819863

Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819863

Immunomodulation of autoimmune and inflammatory diseases with intravenous immunoglobulin

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819863

Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819863

A universal influenza A vaccine based on the extracellular domain of the M2 protein

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819863

Clinical use of immunoglobulins.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819863

Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819863

Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis

27 May 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19788839

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3201/EID1509.090471

1 reference

9 November 2017

1 reference

9 November 2017

PubMed publication ID

19788839

1 reference